Histologic transformation of non‐small‐cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms.

MLA

Shiba, Ishii, Aya, et al. “Histologic Transformation of Non‐small‐cell Lung Cancer in Response to Tyrosine Kinase Inhibitors: Current Knowledge of Genetic Changes and Molecular Mechanisms.” Cancer Science, vol. 115, no. 7, July 2024, pp. 2138–46. EBSCOhost, https://doi.org/10.1111/cas.16192.

APA

Shiba, I. A., Takemura, N., Kawai, H., & Matsubara, D. (2024). Histologic transformation of non‐small‐cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer Science, 115(7), 2138–2146. https://doi.org/10.1111/cas.16192

Chicago

Shiba, Ishii, Aya, Noriko Takemura, Hitomi Kawai, and Daisuke Matsubara. 2024. “Histologic Transformation of Non‐small‐cell Lung Cancer in Response to Tyrosine Kinase Inhibitors: Current Knowledge of Genetic Changes and Molecular Mechanisms.” Cancer Science 115 (7): 2138–46. doi:10.1111/cas.16192.